|
|
||||||||
is required in EGF protection of microtubules and
intestinal barrier integrity against oxidant injury
1 Departments of Internal Medicine (Division of Digestive Diseases), Pharmacology, and Molecular Physiology, Rush University Medical Center, Chicago, Illinois 60612 and 2 Institute of Human Nutrition, Columbia University, New York, New York 10032.
Using monolayers of human
intestinal (Caco-2) cells, we showed that epidermal growth factor (EGF)
protects intestinal barrier integrity against oxidant injury by
protecting the microtubules and that protein kinase C (PKC) is
required. Because atypical PKC-
isoform is abundant in wild-type
(WT) Caco-2 cells, we hypothesized that PKC-
mediates, at least in
part, EGF protection. Intestinal cells (Caco-2 or HT-29) were
transfected to stably over- or underexpress PKC-
. These clones were
preincubated with low or high doses of EGF or a PKC activator
[1-oleoyl-2-acetyl-sn-glycerol (OAG)] before oxidant (0.5 mM H2O2). Relative to WT cells exposed to
oxidant, only monolayers of transfected cells overexpressing PKC-
(2.9-fold) were protected against oxidant injury as indicated by
increases in polymerized tubulin and decreases in monomeric tubulin,
enhancement of architectural stability of the microtubule cytoskeleton,
and increases in monolayer barrier integrity toward control levels (62% less leakiness). Overexpression-induced protection was OAG independent and even EGF independent, but EGF significantly potentiated PKC-
protection. Most overexpressed PKC-
(92%) resided in
membrane and cytoskeletal fractions, indicating constitutive activation of PKC-
. Stably inhibiting PKC-
expression (95%) with antisense transfection substantially attenuated EGF protection as demonstrated by
reduced tubulin assembly and increased microtubule disassembly, disruption of the microtubule cytoskeleton, and loss of monolayer barrier integrity. We conclude that 1) activation of PKC-
is necessary for EGF-induced protection, 2) PKC-
appears
to be an endogenous stabilizer of the microtubule cytoskeleton and of
intestinal barrier function against oxidative injury, and 3)
we have identified a novel biological function (protection) among the
atypical isoforms of PKC.
cytoskeleton; growth factors; epidermal growth factor; Caco-2 cells; gut barrier; protection; transfection; protein kinase C isoforms; inflammatory bowel disease
This article has been cited by other articles:
![]() |
S. A. Siddiqi and C. M. Mansbach II PKC{zeta}-mediated phosphorylation controls budding of the pre-chylomicron transport vesicle J. Cell Sci., July 15, 2008; 121(14): 2327 - 2338. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Mustafi, S. Cerda, A. Chumsangsri, A. Fichera, and M. Bissonnette Protein Kinase-{zeta} Inhibits Collagen I-Dependent and Anchorage-Independent Growth and Enhances Apoptosis of Human Caco-2 Cells Mol. Cancer Res., September 1, 2006; 4(9): 683 - 694. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Farhadi, A. Keshavarzian, Z. Ranjbaran, J. Z. Fields, and A. Banan The Role of Protein Kinase C Isoforms in Modulating Injury and Repair of the Intestinal Barrier J. Pharmacol. Exp. Ther., January 1, 2006; 316(1): 1 - 7. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Fleegal, S. Hom, L. K. Borg, and T. P. Davis Activation of PKC modulates blood-brain barrier endothelial cell permeability changes induced by hypoxia and posthypoxic reoxygenation Am J Physiol Heart Circ Physiol, November 1, 2005; 289(5): H2012 - H2019. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Banan, L. J. Zhang, A. Farhadi, J. Z. Fields, M. Shaikh, C. B. Forsyth, S. Choudhary, and A. Keshavarzian Critical Role of the Atypical {lambda} Isoform of Protein Kinase C (PKC-{lambda}) in Oxidant-Induced Disruption of the Microtubule Cytoskeleton and Barrier Function of Intestinal Epithelium J. Pharmacol. Exp. Ther., February 1, 2005; 312(2): 458 - 471. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Banan, L. J. Zhang, M. Shaikh, J. Z. Fields, A. Farhadi, and A. Keshavarzian Novel effect of NF-{kappa}B activation: carbonylation and nitration injury to cytoskeleton and disruption of monolayer barrier in intestinal epithelium Am J Physiol Cell Physiol, October 1, 2004; 287(4): C1139 - C1151. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Banan, L. J. Zhang, M. Shaikh, J. Z. Fields, A. Farhadi, and A. Keshavarzian Key role of PLC-{gamma} in EGF protection of epithelial barrier against iNOS upregulation and F-actin nitration and disassembly Am J Physiol Cell Physiol, October 1, 2003; 285(4): C977 - C993. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Xu, M. Inouye, E. R. Hines, J. F. Collins, and F. K. Ghishan Transcriptional regulation of the human NaPi-IIb cotransporter by EGF in Caco-2 cells involves c-myb Am J Physiol Cell Physiol, May 1, 2003; 284(5): C1262 - C1271. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Banan, J. Z. Fields, A. Farhadi, D. A. Talmage, L. Zhang, and A. Keshavarzian Activation of delta -Isoform of Protein Kinase C Is Required for Oxidant-Induced Disruption of Both the Microtubule Cytoskeleton and Permeability Barrier of Intestinal Epithelia J. Pharmacol. Exp. Ther., October 1, 2002; 303(1): 17 - 28. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Banan, L. Zhang, J. Z. Fields, A. Farhadi, D. A. Talmage, and A. Keshavarzian PKC-zeta prevents oxidant-induced iNOS upregulation and protects the microtubules and gut barrier integrity Am J Physiol Gastrointest Liver Physiol, October 1, 2002; 283(4): G909 - G922. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |